Dr. Anna Iwan | Medicine | Research Excellence Award
Featured Publications
BKPyV—Co-Architect of the Fate of a Renal Transplant During a One-Year Observation Period
– International Journal of Molecular Sciences, 2026
1000
800
600
400
200
0
View Scopus Profile View ORCID Profile
Mazandaran University of Medical Sciences | Iran
Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.
She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.
Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.
Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.
Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.
Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34
Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97
Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42
Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19
Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63
Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.
Associate Professor at Medical College of Wisconsin, United States
Dr. Laura Glass Umfleet, Psy.D., ABPP (CN), is an accomplished clinical neuropsychologist and Associate Professor of Neurology at the Medical College of Wisconsin. With expertise in adult cognitive disorders, especially neurodegeneration and congenital conditions, she is nationally certified by the American Board of Professional Psychology. Dr. Glass Umfleet serves as an editorial board member and an international leader in data-sharing initiatives. Her contributions span clinical practice, academic mentorship, and scientific collaboration, reinforcing her commitment to advancing neuropsychology through research, education, and open science initiatives. 🌍🧠📚
Dr. Glass Umfleet earned her B.S. in Psychology with a Biology minor in 2006 and an M.S. in Psychology in 2008 from the University of Central Missouri. She completed her Psy.D. in Clinical Psychology from Roosevelt University, Chicago, in 2012 with APA accreditation. Her predoctoral internship at the University of Florida focused on neuropsychology, followed by a postdoctoral fellowship in Clinical Neuropsychology at the Medical College of Wisconsin and the Clement J. Zablocki VA Medical Center. Her educational journey reflects a strong foundation in clinical and cognitive neuroscience. 🎓📖🧬
Since 2014, Dr. Glass Umfleet has served at the Medical College of Wisconsin as a Clinical Neuropsychologist, advancing to Associate Professor in 2021. She is also an Adjunct Assistant Professor at the University of Wisconsin-Milwaukee. Her clinical, academic, and leadership roles reflect her deep involvement in patient care, teaching, and research. Her professional path includes national and international presentations, peer-reviewed workshops, and active roles in neuropsychology organizations, positioning her as a respected expert in her field. 🏥📊👩🏫
Dr. Glass Umfleet’s professional recognition includes board certification in Clinical Neuropsychology by ABPP and editorial positions, such as Associate Editor for the Journal of Alzheimer’s Disease. She has been selected for numerous leadership roles in international neuropsychology societies, including chairing the INS WINDS SIG and serving on committees focused on student mentorship and open science. Her involvement in editorial reviews and scientific programs reflects high standing and trust in her scholarly expertise. 🏅🧠🌟
Dr. Glass Umfleet’s research focuses on cognitive functioning in aging and neurological conditions, including Alzheimer’s disease and adult congenital heart disease. She explores digital neuropsychological assessment, cognitive subtypes, and psychometric methods through collaborative networks like the National Neuropsychology Network. As Chair of INS WINDS, she champions data sharing and precision neuropsychology. Her work bridges clinical insight and innovative methodologies, promoting open science and advancing the field’s understanding of brain-behavior relationships. 🧪🧩💻
🧠 Changes in cerebrovascular reactivity within functional networks in older adults with long-COVID
Year: 2025 | 🧬🧓🦠🧠 Frontiers in Neurology
Year: 2024 | Cited by: 1 | 📊🧠📈📘 Journal of the International Neuropsychological Society
Dr. Laura Glass Umfleet is an exemplary clinical neuropsychologist whose sustained research productivity, innovative methodologies, and impactful publications over nearly two decades underscore her status as a leading figure in the field. Her national and international influence is evident through her leadership roles in global initiatives like the WINDS SIG and ACHD/Neuro Working Group, as well as frequent invited presentations at top-tier conferences. Board-certified by the ABPP and serving as Associate Professor at the Medical College of Wisconsin, Dr. Umfleet pairs academic excellence with clinical relevance. Her dedication to mentoring, editorial service, and advancing open science in neuropsychology further cements her as a highly deserving recipient of a Best Researcher Award.
Catedrática de Universidad, Universitat de Valencia, Spain
👩🔬 Maria A. Aguilar (also known as Maria Asunción Aguilar) is a Full Professor at the University of Valencia in the Department of Psychobiology. With a research focus on psychopharmacology and physiological psychology, she has made significant contributions to understanding the brain mechanisms underlying addiction and stress resilience. Since November 2017, she has held the prestigious position of Catedrático at the University of Valencia.
🎓 Maria A. Aguilar completed her specialization in Psychopharmacology and Physiological Psychology, with a focus on understanding the neural circuits involved in addiction and behavior. Her doctoral thesis was supervised by renowned experts Jose Miñarro and Vicente Simón.
💼 Maria A. Aguilar has had a distinguished academic career, starting as a Professor Titular at the University of Valencia in 2002 and later being promoted to Full Professor in 2017. Her teaching and research primarily focus on psychobiology, particularly studying addiction, drug abuse, and neuroplasticity.
🔬 Her research explores the neurobiological mechanisms of addiction and stress, especially focusing on drug-seeking behavior, neuroplasticity, and the role of glutamatergic receptors. She has conducted extensive studies on the effects of cocaine, MDMA, and cannabidiol on the brain’s reward systems.
🏅 Professor Aguilar has received various accolades throughout her career, including recognition for her groundbreaking research in psychopharmacology and neurobiology. She is a member of several professional organizations and continues to contribute to advancing the understanding of brain mechanisms in behavior.
📝 Top Publications:
Inhibition of Nitric Oxide Synthesis Prevents the Effects of Intermittent Social Defeat on Cocaine-Induced Conditioned Place Preference in Male Mice (2024). Published in Pharmaceuticals DOI: 10.3390/ph17091203. Cited by: 6 articles.
Intermittent voluntary wheel running promotes resilience to the negative consequences of repeated social defeat in mice (2022). Published in Physiology & Behavior DOI: 10.1016/j.physbeh.2022.113916. Cited by: 12 articles.
Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice (2021). Published in Journal of Psychopharmacology DOI: 10.1177/0269881120965952. Cited by: 20 articles.
Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice (2019). Published in European Journal of Neuroscience DOI: 10.1111/ejn.14190. Cited by: 15 articles.
María A. Aguilar is a highly suitable candidate for the Research for Women Award due to her extensive contributions to psychobiology, particularly in the study of drug addiction and stress-related behaviors. Her long academic career, leadership roles, and prolific publication record highlight her dedication to advancing research in neuroscience. To increase her chances of winning, focusing more on the gender-specific implications of her work and enhancing public outreach could further align her profile with the award’s goals.
Associate Professor, University of Washington, United States
Dr. Sandhya R. Panch, MD, MPH, is an esteemed Associate Professor of Medicine at the University of Washington and the Medical Director of Transfusion at the Fred Hutchinson Cancer Center. With a rich background in hematology and transfusion medicine, Dr. Panch has significantly contributed to both academic and clinical fields. Her extensive experience includes roles at the National Institutes of Health and various prestigious institutions, making her a leading expert in her specialty.
Dr. Panch earned her MBBS from Bangalore Medical College and Research Institute in India. She furthered her education with a Master’s in Public Health (Epidemiology and Biostatistics) from the University of Minnesota. Her postdoctoral training includes a residency in Internal Medicine at Georgetown University Hospital, followed by a Clinical Fellowship in Transfusion Medicine at the National Institutes of Health, where she also completed a Post-doctoral Research Fellowship in Molecular Hematopoiesis under the mentorship of Dr. Cynthia E. Dunbar.
Dr. Panch has held numerous prestigious positions throughout her career. Currently, she serves as an Associate Professor at the University of Washington and Medical Director of Transfusion at Fred Hutchinson Cancer Center. Her previous roles include Assistant Research Physician at the NIH Clinical Center and Medical Director at the Center for Cellular Engineering. She has also served as an Attending Physician at NHLBI, NIH, and INOVA SCHAR Cancer Institute, contributing to both clinical practice and research.
Dr. Panch’s research interests are deeply rooted in hematology and transfusion medicine. She focuses on improving hematopoietic progenitor cell mobilization, understanding the impact of manufacturing-related parameters on CAR T-cell product quality, and exploring the safety and efficacy of various treatments for hematologic conditions. Her work aims to enhance patient outcomes through innovative therapeutic approaches and clinical trials.
Dr. Panch has received numerous awards and grants throughout her career, including the National Blood Foundation Early Career Award and the NIH Clinical Center Research Award for Staff Clinicians Program. She has been recognized for her contributions to hematology and transfusion medicine, reflecting her dedication to advancing medical research and patient care.